Open-label, Multicenter, Phase 1b Clinical Trial to Evaluate the Safety and Efficacy of Autologous Claudin 18.2 Chimeric Antigen Receptor T-cell Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma

Protocol No
CARSGEN-CT041-ST-02
Principal Investigator
Ben George
Phase
I
Summary
CAR-T (CT041) in Patients With Gastric or Pancreatic Cancer
Description
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL